Mobia Medical, Inc. (formerly MicroTransponder, Inc.) is a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. The Company's breakthrough Vivistim® Paired VNS™ System is the first FDA-approved implantable solution designed to improve upper limb function in chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Vivistim Paired VNS Therapy combines targeted vagus nerve stimulation with functional movement to promote neuroplasticity and drive meaningful improvements in motor function. For more information, visit Vivistim.com and review safety information at Vivistim.com/safety.
On-site · Canada
Support the clinical integration and adoption of the Vivistim Paired VNS System by training healthcare professionals and monitoring patient progress. Develop territory strategies to increase patient access and achieve implant and sales goals within rehabilitation facilities.
On-site · Canada
Drive the commercial success and adoption of the Vivistim Paired VNS System within a specific geographic region. Build relationships with healthcare providers and clinical teams to identify patient candidates and implement therapy.
